IB
Intero Biosystems
United States · Biotech
Human intestinal organoids for preclinical research and testing.
Product
Intero Biosystems develops miniature human intestinal tissues for preclinical testing. Drug developers and other research teams can use its organoids to study how compounds interact with human biology.
Its stem-cell-derived models include several intestinal tissue components. The Denver company supplies organoids, growth materials and custom research studies.
Funding history
2 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Startup Battlefield award | $100K | TechCrunch — Participant | |
| Pre-seed | $2M | Accelerate Blue Fund — ParticipantAnn Arbor SPARK Capital — ParticipantBronco Venture Fund — ParticipantCanyon Oak Ventures — ParticipantEvoce Capital — ParticipantGoose Capital — ParticipantHouston Angel Network — ParticipantKalamazoo Forward Ventures — ParticipantMichigan Biomedical Venture Fund — ParticipantMichigan Rise — ParticipantMichigan University Innovation Capital Fund — ParticipantNancy Chang — ParticipantnCourage Investment Group — Participant |